Galmed Pharmaceuticals Ltd. buy StockNews.com
Start price
11.03.23
/
50%
€0.42
Target price
11.03.24
-
Performance (%)
-21.70%
End price
12.03.24
€0.33
Summary
This prediction ended on 12.03.24 with a price of €0.33. The prediction for Galmed Pharmaceuticals Ltd. disappointed with a performance of -21.70%. StockNews_com has a follow-up prediction for Galmed Pharmaceuticals Ltd. where he still thinks Galmed Pharmaceuticals Ltd. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | 0.760% | 1.149% | 17.258% |
| iShares Nasdaq 100 | 0.732% | 1.884% | 8.152% |
| iShares Nikkei 225® | 1.025% | -0.865% | 13.066% |
| iShares S&P 500 | -0.036% | 1.480% | 3.393% |
Comments by StockNews_com for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten